Biotin Supplements for Hair and Nail Regrowth: What Patients With Cancer Should Know
- 1 day ago
- 2 min read
Layna Mager et al. Biotin Supplements for Hair and Nail Regrowth: A Caution for Oncologists. JCO Oncol Pract 0, OP-25-00693. DOI:10.1200/OP-25-00693
Why This Study Matters
Hair thinning and nail changes are common side effects of cancer treatment. Many patients turn to over-the-counter supplements marketed to improve hair, skin, and nail health — especially biotin (vitamin B7).
This review highlights an important concern: while biotin is widely viewed as harmless, it may interfere with laboratory tests used to monitor cancer and guide treatment decisions.
What Researchers Reviewed
Researchers examined existing evidence on biotin supplementation, including:
How commonly biotin is used
Whether it truly improves hair or nail regrowth
Potential risks for patients undergoing cancer treatment
Biotin supplements are frequently marketed for cosmetic benefits, yet true biotin deficiency is rare in the general population. Evidence supporting routine supplementation for hair or nail regrowth in people without deficiency remains limited.
Key Findings
1. Biotin Can Affect Cancer-Related Blood Tests
Many modern laboratory tests rely on biotin-based technology. High levels of supplemental biotin in the bloodstream can disrupt these assays, producing incorrect test results.
This interference may affect:
Hormone testing
Cardiac markers
Tumor marker measurements used in cancer monitoring
As a result, lab values may appear falsely elevated or falsely low, potentially complicating treatment decisions.
2. Supplement Use Is Often Underreported
Patients may not consider vitamins or supplements important to mention during medical visits. However, researchers emphasize that undisclosed supplement use creates safety risks because clinicians may not recognize laboratory interference as the cause of abnormal results.
3. Benefits May Be Limited
The review found little strong evidence that biotin improves hair or nail growth in individuals who are not deficient. Despite widespread marketing claims, routine supplementation may provide minimal benefit while introducing avoidable risks during cancer care.
What This Means for Patients
If you are undergoing cancer treatment:
Tell your oncology team about all vitamins and supplements you take.
Do not start supplements without medical guidance.
Your care team may recommend stopping biotin before blood testing.
Ask about evidence-based options for managing treatment-related hair loss.
Even common supplements can influence how doctors interpret treatment response.
This research reinforces an important message for patients navigating cancer treatment: “natural” does not always mean risk-free. Accurate laboratory monitoring is essential for making treatment decisions, and supplements can sometimes interfere in unexpected ways.
Open communication between patients and care teams helps ensure treatments remain safe, effective, and appropriately monitored throughout the cancer journey.
